CH642083A5 - Processo per la preparazione di l-alpha-glicerilfosforilcolina. - Google Patents
Processo per la preparazione di l-alpha-glicerilfosforilcolina. Download PDFInfo
- Publication number
- CH642083A5 CH642083A5 CH90080A CH90080A CH642083A5 CH 642083 A5 CH642083 A5 CH 642083A5 CH 90080 A CH90080 A CH 90080A CH 90080 A CH90080 A CH 90080A CH 642083 A5 CH642083 A5 CH 642083A5
- Authority
- CH
- Switzerland
- Prior art keywords
- glycerylphosphorylcholine
- lecithin
- preparation
- solution
- moles
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000008777 Glycerylphosphorylcholine Substances 0.000 title description 10
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 title 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 18
- 229940067606 lecithin Drugs 0.000 claims description 17
- 235000010445 lecithin Nutrition 0.000 claims description 17
- 239000000787 lecithin Substances 0.000 claims description 17
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 12
- 238000006140 methanolysis reaction Methods 0.000 claims description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 9
- SUHOQUVVVLNYQR-MRVPVSSYSA-O glycerylphosphorylcholine Chemical compound C[N+](C)(C)CCO[P@](O)(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-O 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 238000005227 gel permeation chromatography Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- -1 fatty acid esters Chemical class 0.000 description 4
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000008344 egg yolk phospholipid Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000013400 Quercus lobata Nutrition 0.000 description 1
- 240000001749 Quercus lobata Species 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25761/79A IT1123187B (it) | 1979-09-17 | 1979-09-17 | Processo per la preparazione di l-alfa-glicerilfosforilcolina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH642083A5 true CH642083A5 (it) | 1984-03-30 |
Family
ID=11217655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH90080A CH642083A5 (it) | 1979-09-17 | 1980-02-05 | Processo per la preparazione di l-alpha-glicerilfosforilcolina. |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5643290A (fr) |
| AR (1) | AR225159A1 (fr) |
| CH (1) | CH642083A5 (fr) |
| DE (1) | DE3000246C2 (fr) |
| ES (1) | ES8100307A1 (fr) |
| FR (1) | FR2464961A1 (fr) |
| GB (1) | GB2058792A (fr) |
| IT (1) | IT1123187B (fr) |
| MX (1) | MX6294E (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT383130B (de) * | 1984-05-15 | 1987-05-25 | Chemie Linz Ag | Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin |
| IT1201477B (it) * | 1985-10-04 | 1989-02-02 | Istituto Chemioterapico | Procedimento per la preparazione di l-alfa-glicerilfosforilcolina,l-alfa-glicerilfosforiletanolommina e l-alfa-glicerilfosforilinositolo da lecitine grezze e/o deoleate |
| JPH066744B2 (ja) * | 1986-05-15 | 1994-01-26 | 住友金属工業株式会社 | 高Ｎｉ−Ｆｅ合金熱延鋼板の製造方法 |
| JP2572757B2 (ja) * | 1986-11-27 | 1997-01-16 | 川崎製鉄株式会社 | 熱間圧延設備における鋼片の処理方法および鋼片の処理装置 |
| FR2614621B1 (fr) * | 1987-04-29 | 1989-08-11 | Ire Celltarg Sa | Procede de purification des phosphatidylcholines et produits obtenus |
| CN103193821A (zh) * | 2013-03-29 | 2013-07-10 | 山东罗欣药业股份有限公司 | L-α-甘油磷酰胆碱的合成方法 |
| CN109134532A (zh) * | 2018-07-19 | 2019-01-04 | 芜湖福民生物药业股份有限公司 | 采用大豆粉末磷脂制备甘油磷脂酰胆碱的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2864848A (en) * | 1954-07-19 | 1958-12-16 | Ca Nat Research Council | Method of producing l-alpha-glycerylphosphorylcholine |
-
1979
- 1979-09-17 IT IT25761/79A patent/IT1123187B/it active Protection Beyond IP Right Term
- 1979-12-13 GB GB7942951A patent/GB2058792A/en not_active Withdrawn
- 1979-12-19 AR AR279371A patent/AR225159A1/es active
- 1979-12-28 JP JP17395979A patent/JPS5643290A/ja active Granted
-
1980
- 1980-01-04 ES ES487473A patent/ES8100307A1/es not_active Expired
- 1980-01-05 DE DE3000246A patent/DE3000246C2/de not_active Expired
- 1980-01-18 FR FR8001090A patent/FR2464961A1/fr active Granted
- 1980-01-22 MX MX808602U patent/MX6294E/es unknown
- 1980-02-05 CH CH90080A patent/CH642083A5/it not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2464961B1 (fr) | 1985-05-17 |
| ES487473A0 (es) | 1980-11-01 |
| MX6294E (es) | 1985-03-18 |
| FR2464961A1 (fr) | 1981-03-20 |
| JPS6341920B2 (fr) | 1988-08-19 |
| JPS5643290A (en) | 1981-04-21 |
| DE3000246A1 (de) | 1981-04-02 |
| IT1123187B (it) | 1986-04-30 |
| DE3000246C2 (de) | 1989-02-02 |
| GB2058792A (en) | 1981-04-15 |
| AR225159A1 (es) | 1982-02-26 |
| ES8100307A1 (es) | 1980-11-01 |
| IT7925761A0 (it) | 1979-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0922707B2 (fr) | Un procédé de purification de la phosphatidylsérine | |
| JP2883202B2 (ja) | Ｌ―アルファ―グリセリルホスホリルコリンおよびｌ―アルファ―グリセリルホスホリルエタノールアミンの製造法 | |
| US5315023A (en) | Process for the preparation of glycerophospholipids | |
| CH642083A5 (it) | Processo per la preparazione di l-alpha-glicerilfosforilcolina. | |
| EP0063106B1 (fr) | Procédé de préparation d'acide ursodéoxymycholique de haute pureté | |
| EP0036583A2 (fr) | Ester halogénoalcoyle d'acide glycérine-3-phosphorique et procédé pour sa préparation et son post-traitement | |
| US2457932A (en) | Salts of tocopheryl phosphoric | |
| EP0217765B1 (fr) | Procédé de préparation de L-alpha-glycérylphosphorylcholine et de L-alpha-glycérylphosphoryléthanolamine à partir de lécithines crues et/ou dont l'acide oléique a été éliminé | |
| US5306840A (en) | Process for preparing pure L-α-glycerylphosphoryl-D-myoinositol and its salts | |
| US3176029A (en) | Preparation of vitamin d3 | |
| Rathbone et al. | The preparation and properties of lysophosphatidylserine | |
| US3875196A (en) | Process for preparing phosphoric acid esters of fatty acid mono- or di-glycerides | |
| EP0335396A1 (fr) | Dérivés d'acides glycéro-phosphoriques et diphosphoriques de la L-carnitine ou d'esters de la L-carnitine | |
| CN111253434A (zh) | 一种二棕榈酰磷脂酸的制备方法 | |
| JPS58179437A (ja) | 高含量のホスフアチジルコリンを有する粗製物の製造方法 | |
| Brown et al. | 390. Phospholipids. Part I. The hydrolysis of some esters of cyclo hexanediol phosphates | |
| US3836550A (en) | Chenodeoxycholic acid | |
| US2899449A (en) | Phosphatidyl choline compounds | |
| EP0065390A1 (fr) | Purification d'esters de sucrose | |
| RU1085210C (ru) | Способ получени @ -циклоцитидин- @ -монофосфата и его производных | |
| IT9019895A1 (it) | Procedimento per la separazione dei principali componenti di una miscela di fosfolipidi grezzi deacilati | |
| CN110172074A (zh) | 一种阿德福韦酯的合成方法 | |
| Urakami et al. | Selective Reduction of Phosphatides with Lithium Aluminum Hydride. II. Reductive Cleavage of Phosphatidic Acid | |
| JPH01203385A (ja) | プロトポルフィリンジエステルの製造方法 | |
| JC et al. | The isolation of a new lipid, triphosphoinositide, and monophosphoinositide from ox brain. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |